RRC ID 62863
著者 Inubushi T, Kosai A, Yanagisawa S, Chanbora C, Miyauchi M, Yamasaki S, Sugiyama E, Ishikado A, Makino T, Takata T.
タイトル Bovine lactoferrin enhances osteogenesis through Smad2/3 and p38 MAPK activation.
ジャーナル J Oral Biosci
Abstract OBJECTIVES:Lactoferrin (LF) possesses diverse biological functions. We previously reported that bovine LF (bLF) attenuates lipopolysaccharide-induced bone resorption in osteoblasts. In addition to its ability to inhibit osteoclastogenesis, bLF has been implicated in stimulating bone formation. However, the molecular mechanisms of bLF in bone cell anabolism remain unclear. Here, we tried to analyse the molecular mechanisms involved in osteogenesis in the presence of bLF.
METHODS:Alkaline phosphatase activity, Runx2 activity, gene expression, and Alizarin red staining were analyzed to evaluate the osteogenic differentiation status. The expression of the Smads and mitogen-activated protein kinase (MAPK) signaling molecules was analyzed via western blotting. Ex vivo organ cultures of mouse calvariae were performed to evaluate the effect of bLF on bone regeneration.
RESULTS:bLF enhanced the osteoblastic differentiation of mesenchymal stem cells through activation of Smad2/3 and p38 MAPK, which increased the transcriptional activity of Runx2. bLF treatment also enhanced osteoblastic differentiation and mineralized nodule formation of osteoblast-lineage cells, and repaired bone defects ex vivo. Moreover, inhibition of Smad2/3 or p38 MAPK signaling reduced the anabolic effects of bLF. Together, these results suggested that bLF is a potent osteogenic factor, which mediates its function via activation of the Smad2/3 and p38 MAPK signaling pathways.
CONCLUSIONS:Here, we described a novel function of bLF and its signal transduction mechanisms in osseous tissue. Along with inhibiting osteoclastogenesis, bLF may limit further osteoclast formation and contribute to bone mass enlargement. Thus, bLF represents a potentially valuable therapeutic agent for bone regeneration and destructive bone diseases.
巻・号 62(2)
ページ 147-154
公開日 2020-6-1
DOI 10.1016/j.job.2020.05.001
PII S1349-0079(20)30051-7
PMID 32464258
MeSH Animals Cell Differentiation Lactoferrin* Mice Osteoblasts Osteoclasts Osteogenesis* Smad2 Protein Smad3 Protein p38 Mitogen-Activated Protein Kinases
リソース情報
ヒト・動物細胞 C2C12(RCB0987) MC3T3-E1(RCB1126)